Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$130.81
3.012.36%
At close: -
$130.81
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Itron Analyst Ratings and Price Targets | NASDAQ:ITRI | Benzinga
Itron Inc has a consensus price target of $102.35 based on the ratings of 18 analysts. The high is $136 issued by TD Cowen on November 1, 2024. The low is $50 issued by Morgan Stanley on November 4, 2022. The 3 most-recent analyst ratings were released by Piper Sandler, Guggenheim, and Guggenheim on May 5, 2025, April 17, 2025, and February 27, 2025, respectively. With an average price target of $129 between Piper Sandler, Guggenheim, and Guggenheim, there's an implied -1.38% downside for Itron Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Guggenheim
Canaccord Genuity
Oppenheimer
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Itron
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/05/2025 | Buy Now | -7.5% | Piper Sandler | Kashy Harrison43% | $124 → $121 | Maintains | Neutral | Get Alert |
| 04/17/2025 | Buy Now | 1.67% | Guggenheim | Joseph Osha81% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2025 | Buy Now | 1.67% | Guggenheim | Joseph Osha81% | $135 → $133 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | -5.21% | Piper Sandler | Kashy Harrison43% | $119 → $124 | Maintains | Neutral | Get Alert |
| 02/26/2025 | Buy Now | 0.91% | Canaccord Genuity | Austin Moeller46% | $130 → $132 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 0.15% | Oppenheimer | Noah Kaye74% | $124 → $131 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 3.2% | Guggenheim | Joseph Osha81% | $128 → $135 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 3.97% | TD Cowen | Jeffrey Osborne28% | $125 → $136 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | -0.62% | Roth MKM | Chip Moore65% | $125 → $130 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | -9.03% | Piper Sandler | Kashy Harrison43% | $110 → $119 | Maintains | Neutral | Get Alert |
| 11/01/2024 | Buy Now | -5.21% | Oppenheimer | Noah Kaye74% | $120 → $124 | Maintains | Outperform | Get Alert |
| 11/01/2024 | Buy Now | 0.91% | Baird | Ben Kallo47% | $123 → $132 | Maintains | Outperform | Get Alert |
| 09/27/2024 | Buy Now | 0.15% | Janney Montgomery Scott | Sean Milligan44% | → $131 | Initiates | → Buy | Get Alert |
| 08/21/2024 | Buy Now | -4.44% | Roth MKM | Chip Moore65% | $125 → $125 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | -15.91% | Stephens & Co. | Tommy Moll73% | $110 → $110 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2024 | Buy Now | -4.44% | Roth MKM | Chip Moore65% | $122 → $125 | Maintains | Buy | Get Alert |
| 08/02/2024 | Buy Now | -5.97% | Baird | Ben Kallo47% | $115 → $123 | Maintains | Outperform | Get Alert |
| 07/22/2024 | Buy Now | -15.91% | Piper Sandler | Kashy Harrison43% | $109 → $110 | Maintains | Neutral | Get Alert |
| 07/17/2024 | Buy Now | -14.38% | Oppenheimer | Noah Kaye74% | $110 → $112 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | -14.38% | JP Morgan | Mark Strouse67% | $104 → $112 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | -6.73% | Roth MKM | Chip Moore65% | $112 → $122 | Maintains | Buy | Get Alert |
| 07/11/2024 | Buy Now | -0.62% | Guggenheim | Joseph Osha81% | → $130 | Upgrade | Neutral → Buy | Get Alert |
| 06/20/2024 | Buy Now | -8.26% | Canaccord Genuity | Austin Moeller46% | $115 → $120 | Maintains | Buy | Get Alert |
| 05/21/2024 | Buy Now | -16.67% | Piper Sandler | Kashy Harrison43% | $109 → $109 | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2024 | Buy Now | -15.91% | Stephens & Co. | Tommy Moll73% | $85 → $110 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | -12.09% | Canaccord Genuity | Austin Moeller46% | $105 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | -12.09% | TD Cowen | Jeffrey Osborne28% | $110 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | -14.38% | Roth MKM | Chip Moore65% | $102 → $112 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | -16.67% | Piper Sandler | Kashy Harrison43% | $103 → $109 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | Buy Now | -15.91% | Oppenheimer | Noah Kaye74% | $100 → $110 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | -22.02% | Roth MKM | Chip Moore65% | → $102 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | -21.26% | Piper Sandler | Kashy Harrison43% | $105 → $103 | Maintains | Overweight | Get Alert |
| 03/13/2024 | Buy Now | -15.91% | TD Cowen | Jeffrey Osborne28% | $107 → $110 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | -12.09% | Baird | Ben Kallo47% | $108 → $115 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | -29.67% | JP Morgan | Mark Strouse67% | $77 → $92 | Maintains | Neutral | Get Alert |
| 02/27/2024 | Buy Now | -19.73% | Piper Sandler | Kashy Harrison43% | $91 → $105 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | -17.44% | Baird | Ben Kallo47% | $68 → $108 | Upgrade | Neutral → Outperform | Get Alert |
| 01/19/2024 | Buy Now | -38.08% | Oppenheimer | Noah Kaye74% | → $81 | Upgrade | Perform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Raymond James | Pavel Molchanov50% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/19/2023 | Buy Now | -30.43% | Piper Sandler | Kashy Harrison43% | $72 → $91 | Upgrade | Neutral → Overweight | Get Alert |
| 12/12/2023 | Buy Now | -48.02% | JP Morgan | Paul Coster69% | → $68 | Upgrade | Underweight → Neutral | Get Alert |
| 12/05/2023 | Buy Now | -37.31% | Roth MKM | Chip Moore65% | → $82 | Initiates | → Buy | Get Alert |
| 12/01/2023 | Buy Now | -48.02% | Canaccord Genuity | Austin Moeller46% | → $68 | Initiates | → Hold | Get Alert |
| 11/03/2023 | Buy Now | -44.96% | Piper Sandler | Kashy Harrison43% | $71 → $72 | Maintains | Neutral | Get Alert |
| 10/19/2023 | Buy Now | -50.31% | JP Morgan | Paul Coster69% | $72 → $65 | Maintains | Underweight | Get Alert |
| 10/06/2023 | Buy Now | -45.72% | Piper Sandler | Kashy Harrison43% | $63 → $71 | Maintains | Neutral | Get Alert |
| 09/22/2023 | Buy Now | -38.84% | Seaport Global | Scott Graham74% | → $80 | Initiates | → Buy | Get Alert |
| 09/11/2023 | Buy Now | — | Guggenheim | Joseph Osha81% | — | Initiates | → Neutral | Get Alert |
| 08/18/2023 | Buy Now | -37.31% | Argus Research | John Eade74% | → $82 | Upgrade | Hold → Buy | Get Alert |
| 08/04/2023 | Buy Now | -27.38% | TD Cowen | Jeffrey Osborne28% | $85 → $95 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | -42.66% | Baird | Ben Kallo47% | $63 → $75 | Maintains | Neutral | Get Alert |
| 07/12/2023 | Buy Now | — | Raymond James | Pavel Molchanov50% | — | Downgrade | Strong Buy → Outperform | Get Alert |
| 05/08/2023 | Buy Now | -51.84% | Piper Sandler | Kashy Harrison43% | $58 → $63 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -46.49% | EF Hutton | Chip Moore65% | $60 → $70 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | -51.84% | Baird | Ben Kallo47% | $52 → $63 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -46.49% | Raymond James | Pavel Molchanov50% | $60 → $70 | Maintains | Strong Buy | Get Alert |
| 03/03/2023 | Buy Now | -61.78% | JP Morgan | Paul Coster69% | $53 → $50 | Downgrade | Neutral → Underweight | Get Alert |
| 02/28/2023 | Buy Now | -65.6% | Stephens & Co. | Tommy Moll73% | → $45 | Reiterates | → Equal-Weight | Get Alert |
| 02/28/2023 | Buy Now | -55.66% | Piper Sandler | Kashy Harrison43% | $48 → $58 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -60.25% | Baird | Ben Kallo47% | $40 → $52 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -54.13% | EF Hutton | Chip Moore65% | → $60 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | -54.13% | Raymond James | Pavel Molchanov50% | $57 → $60 | Maintains | Strong Buy | Get Alert |
| 02/02/2023 | Buy Now | -44.96% | Cowen & Co. | Jeffrey Osborne28% | $55 → $72 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | -61.78% | Morgan Stanley | Connor Lynagh58% | $55 → $50 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -54.13% | EF Hutton | Chip Moore65% | $72 → $60 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | -56.43% | Raymond James | Pavel Molchanov50% | $68 → $57 | Maintains | Strong Buy | Get Alert |
| 10/20/2022 | Buy Now | -55.66% | JP Morgan | Mark Strouse67% | $65 → $58 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | — | JP Morgan | Paul Coster69% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/05/2022 | Buy Now | -57.95% | Stephens & Co. | Tommy Moll73% | $65 → $55 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | -44.19% | JP Morgan | Mark Strouse67% | $71 → $73 | Maintains | Overweight | Get Alert |
| 07/19/2022 | Buy Now | -61.78% | Piper Sandler | Pearce Hammond33% | $51 → $50 | Maintains | Neutral | Get Alert |
| 07/12/2022 | Buy Now | -48.02% | Raymond James | Pavel Molchanov50% | $72 → $68 | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for Itron (ITRI) stock?
The latest price target for Itron (NASDAQ:ITRI) was reported by Piper Sandler on May 5, 2025. The analyst firm set a price target for $121.00 expecting ITRI to fall to within 12 months (a possible -7.50% downside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Itron (ITRI)?
The latest analyst rating for Itron (NASDAQ:ITRI) was provided by Piper Sandler, and Itron maintained their neutral rating.
When was the last upgrade for Itron (ITRI)?
The last upgrade for Itron Inc happened on July 11, 2024 when Guggenheim raised their price target to $130. Guggenheim previously had a neutral for Itron Inc.
When was the last downgrade for Itron (ITRI)?
The last downgrade for Itron Inc happened on May 21, 2024 when Piper Sandler changed their price target from $109 to $109 for Itron Inc.
When is the next analyst rating going to be posted or updated for Itron (ITRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Itron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Itron was filed on May 5, 2025 so you should expect the next rating to be made available sometime around May 5, 2026.
Is the Analyst Rating Itron (ITRI) correct?
While ratings are subjective and will change, the latest Itron (ITRI) rating was a maintained with a price target of $124.00 to $121.00. The current price Itron (ITRI) is trading at is $130.81, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
